Mycobacterium indicus pranii vaccination-induced cutaneous granuloma in COVID-19 patients
Main Authors: | Yapamakula Anisha Amarnath, Vinutha Rangappa, Veeranna Shastry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Indian Dermatology Online Journal |
Online Access: | http://www.idoj.in/article.asp?issn=2229-5178;year=2023;volume=14;issue=6;spage=908;epage=909;aulast=Amarnath |
Similar Items
-
Persistent exaggerated granulomatous hypersensitivity reaction to Mycobacterium indicus pranii immunomodulatory therapy for COVID-19 sepsis
by: Nikhil Mehta, et al.
Published: (2023-01-01) -
Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
by: Manila Purushottam, et al.
Published: (2023-01-01) -
Mycobacterium indicus pranii (MIP) vaccine: Pharmacology, indication, dosing schedules, administration, and side effects in clinical practice
by: Sunil Dogra, et al.
Published: (2023-01-01) -
Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii
by: Gargi Roy, et al.
Published: (2023-04-01) -
Role of Mycobacterium indicus pranii in clinical outcomes in patients with sepsis: A systematic review and meta-analysis of randomised controlled trials
by: Khushboo Saran, et al.
Published: (2023-01-01)